Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoosier Cancer Research Network
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
European Organisation for Research and Treatment of Cancer - EORTC
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Duke University
Emory University
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
AGO Study Group
Pediatric Brain Tumor Consortium